Proudly Serving Clients Throughout Arkansas

Free Consultations Available


$830 Million Settlement of Transvaginal Mesh Cases

$830 Million Settlement of Transvaginal Mesh Cases

Endo International Agrees To Settle 20,000 Claims

Beleaguered pharmaceutical and medical manufacturer giant, Endo International Plc, has agreed to pay $830 million to settle approximately 20,000 pending claims related to the company’s transvaginal mesh implant. The agreement came on Wednesday, April 30, 2014. This comes on the heels of the company’s $54.5 million settlement, which it handed out just last year in another round of transvaginal mesh settlement claims.

What Are Transvaginal Mesh Devices?

Transvaginal mesh devices go by many different names and are manufactured by numerous companies and their subsidiaries. These implants are also known as pelvic mesh, pelvic slings, pelvic supports, and bladder slings. Surgeons and physicians use transvaginal mesh implants to treat pelvic organ prolapse and urinary incontinence. There have been widespread reports of women suffering severe complications after receiving a transvaginal device implant. Complications include organ perforation, bleeding, painful sexual intercourse, infection, organ erosion, bladder and bowel incontinence, and severe pain.

A wide range of manufacturers, including Johnson & Johnson, C.R. Bard, Boston Scientific, American Medical System, and Johnson & Johnson’s Ethicon Unit, have come under fire for failing to alert the public to the dangers associated with these devices.

Have Transvaginal Mesh Devices Been Recalled?

Despite the numerous lawsuits filed against the manufacturers of these devices, no transvaginal mesh implant products have been recalled. However, the FDA issued asafety communication to consumers in 2011 warning individuals that complications stemming from these devices are far from rare and that transvaginal mesh products have been known to produce serious problems.

Furthermore, in 2012, the FDA ordered American Medical System and other manufacturers to study and monitor the rate of adverse events related to transvaginal mesh devices.